OS Therapies Incorporated (OSTX) is a publicly traded Healthcare sector company. As of October 6, 2026, OSTX trades at $1.73 with a market cap of $75.82M and a P/E ratio of -1.65. OSTX moved +5.01% today. Year to date, OSTX is +14.29%; over the trailing twelve months it is -20.79%. Its 52-week range spans $1.12 to $2.98. Analyst consensus is strong buy with an average price target of $8.67. Rallies surfaces OSTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for OSTX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.73 |
| Market Cap | $75.82M |
| P/E Ratio | -1.65 |
| EPS | $-0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.98 |
| 52-Week Low | $1.12 |
| Volume | 3.79M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-28.75M |
| Gross Margin | 0.00% |
3 analysts cover OSTX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.67.